GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Graft Polymer (UK) PLC (LSE:GPL) » Definitions » Debt-to-EBITDA

Graft Polymer (UK) (LSE:GPL) Debt-to-EBITDA : -0.01 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Graft Polymer (UK) Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Graft Polymer (UK)'s Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was £0.01 Mil. Graft Polymer (UK)'s Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was £0.02 Mil. Graft Polymer (UK)'s annualized EBITDA for the quarter that ended in Dec. 2023 was £-3.82 Mil. Graft Polymer (UK)'s annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.01.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Graft Polymer (UK)'s Debt-to-EBITDA or its related term are showing as below:

LSE:GPL' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.95   Med: -0.43   Max: -0.01
Current: -0.01

During the past 6 years, the highest Debt-to-EBITDA Ratio of Graft Polymer (UK) was -0.01. The lowest was -1.95. And the median was -0.43.

LSE:GPL's Debt-to-EBITDA is ranked worse than
100% of 2280 companies
in the Industrial Products industry
Industry Median: 1.695 vs LSE:GPL: -0.01

Graft Polymer (UK) Debt-to-EBITDA Historical Data

The historical data trend for Graft Polymer (UK)'s Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Graft Polymer (UK) Debt-to-EBITDA Chart

Graft Polymer (UK) Annual Data
Trend May18 May19 May20 May21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial -0.66 -1.62 -1.95 -0.01 -0.01

Graft Polymer (UK) Semi-Annual Data
May18 May19 May20 May21 Jun22 Dec22 Jun23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial N/A - -0.01 -0.02 -0.01

Competitive Comparison of Graft Polymer (UK)'s Debt-to-EBITDA

For the Specialty Industrial Machinery subindustry, Graft Polymer (UK)'s Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Graft Polymer (UK)'s Debt-to-EBITDA Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Graft Polymer (UK)'s Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Graft Polymer (UK)'s Debt-to-EBITDA falls into.



Graft Polymer (UK) Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Graft Polymer (UK)'s Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.012 + 0.022) / -2.938
=-0.01

Graft Polymer (UK)'s annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.012 + 0.022) / -3.818
=-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.


Graft Polymer (UK)  (LSE:GPL) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Graft Polymer (UK) Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Graft Polymer (UK)'s Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Graft Polymer (UK) (LSE:GPL) Business Description

Traded in Other Exchanges
Address
Eccleston Yards, 25 Eccleston Place, London, GBR, SW1W 9NF
Graft Polymer (UK) PLC focuses on the development of polymer modification and drug delivery systems. It has licensed its Drug Delivery System platform IP to MGC Pharmaceuticals in relation to MGC Pharma's CimetrA product. The group's products address customer needs across a wide range of end-use markets, from automotive through to medical, and are not dependent on one market segment.

Graft Polymer (UK) (LSE:GPL) Headlines

No Headlines